mTOR Signalling in Neurodegenerative Disorders: Unveiling Key Factors, Mechanistic Insights, and Possible Therapeutic Interventions
Cellular Physiology and Biochemistry · 2026
DOI: 10.33594/000000858 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cellular Physiology and Biochemistry, 2026. Verfasst von Niraj Kumar Jha und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Bioengineering, Galgotias University, India. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Signal Transduction, Neurodegenerative Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Neurodegenerative diseases (NDDs) are defined by the gradual degeneration of neuronal cells, wherein the accumulation of misfolded proteins can lead to memory impairments, motor dysfunctions, and other deteriorations. Despite the widespread impact, there are currently no viable pharmaceuticals to treat these disorders. Currently, more than 30 million individuals globally endure severe health issues, with few therapeutic alternatives for their management. The mTOR protein is a crucial regulator of cell death signals, survival, growth, and the fate of neural cells. Targeted modulation of mTOR signaling holds the potential for mitigating neurodegeneration in Alzheimer's, Huntington's, Amyotrophic Lateral Sclerosis (ALS), Parkinson's, and other neurodegenerative conditions. However, the advancement of successful mTOR-targeted therapeutics necessitates careful consideration of multiple factors. These include addressing protein aggregation and comprehending the complex interactions of cell death pathways within the neurological system. Additionally, mTOR modulates diverse signaling pathways, encompassing growth factors and proteins, including PI3K (phosphoinositide 3-kinase), Akt, AMPK, and SIRT1. Understanding these connections is crucial for effective therapeutic development. By comprehending the intricacies of the mTOR pathway, researchers have the opportunity to uncover novel and more precise therapies, offering optimism for the future management of NDDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology and Bioengineering, Galgotias University, India.
- Department of Biotechnology Engineering and Food Technology, Chandigarh University, India.
- Department of Pharmaceutical Sciences, Maharshi Dayanand University, India.
- Department of Medical Laboratory Sciences, University of Bisha, Saudi Arabia.
- Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, India.
- Department of Biomedical Sciences, Abu Dhabi University, UAE.
Zitieren
APA
Jha, N. K., Chauhan, P., Abomughaid, M. M., Avinash, D., Almutary, A. G., Lakhanpal, S., Singh, A., Sulaimani, G. M., Al-Kuraishy, H. M., Mohammed, H. A., Misra, J., Thakur, K., & Kumar, D. (2026). mTOR Signalling in Neurodegenerative Disorders: Unveiling Key Factors, Mechanistic Insights, and Possible Therapeutic Interventions. Cellular Physiology and Biochemistry. https://doi.org/10.33594/000000858
Vancouver
Jha NK, Chauhan P, Abomughaid MM, Avinash D, Almutary AG, Lakhanpal S, et al. mTOR Signalling in Neurodegenerative Disorders: Unveiling Key Factors, Mechanistic Insights, and Possible Therapeutic Interventions. Cellular Physiology and Biochemistry. 2026. doi:10.33594/000000858
BibTeX
@article{Jha2026,
author = {Jha, Niraj Kumar and Chauhan, Payal and Abomughaid, Mosleh Mohammad and Avinash, D and Almutary, Abdulmajeed G and Lakhanpal, Sorabh and Singh, Ajay and Sulaimani, Ghassan M and Al-Kuraishy, Hayder M and Mohammed, Hamdoon A and Misra, Jyotsna and Thakur, Kunal and Kumar, Dhruv},
title = {mTOR Signalling in Neurodegenerative Disorders: Unveiling Key Factors, Mechanistic Insights, and Possible Therapeutic Interventions},
journal = {Cellular Physiology and Biochemistry},
year = {2026},
doi = {10.33594/000000858}
}
EUVIMED